Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - INTEGRATED ENVIRONMENTAL TECHNOLOGIES, LTD. | f8k072312ex99i_integrated.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 23, 2012
INTEGRATED ENVIRONMENTAL TECHNOLOGIES, LTD.
(Exact name of registrant as specified in charter)
|
Nevada
|
000-26309
|
98-0200471
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
4235 Commerce Street, Little River, South Carolina
|
29566
|
||
|
(Address of principal executive offices)
|
(Zip Code)
|
||
Registrant’s telephone number, including area code: (843) 390-2500
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Section 8 – Other Events
Item 8.01. Other Events.
On July 23, 2012, Integrated Environmental Technologies, Ltd. (the “Company”) issued a press release announcing that that it had completed a series of tests on its Excelyte® disinfecting solution at an independent EPA approved laboratory. Excelyte® was successful in eliminating three hospital acquired pathogens, C. difficile spores, K. pneumonia and Vacomycin Resistant Enterococcus (VRE) and in eliminating the high-risk blood borne pathogen HIV and the food borne pathogens Listeria and E. coli. The Company also announced that it will begin the process of amending its EPA master label claims to include the above pathogens.
A copy of the press release is attached hereto as Exhibit 99.1.
Section 9 – Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
|
Exhibit
No.
|
Description
|
|
99.1
|
Press Release Re: Integrated Environmental Technologies, Ltd. Announces Successful Excelyte® Test Results Conducted by an Independent EPA Approved Laboratory.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
INTEGRATED ENVIRONMENTAL TECHNOLOGIES, LTD.
|
|||
|
July 24, 2012
|
By:
|
/s/ David R. LaVance | |
|
David R. LaVance
|
|||
|
President and Chief Executive Officer
|
|||
EXHIBIT INDEX
|
Exhibit
No.
|
Description
|
|
99.1
|
Press Release Re: Integrated Environmental Technologies, Ltd. Announces Successful Excelyte® Test Results Conducted by an Independent EPA Approved Laboratory.
|